Skip to main content
Clinical Trials/NCT03364322
NCT03364322
Completed
Not Applicable

Prospective Study for Influencing Factors on Dry Eye Syndrome, Ocular Surface Disease and Treatment

Hallym University Kangnam Sacred Heart Hospital1 site in 1 country200 target enrollmentJune 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dry Eye Syndrome
Sponsor
Hallym University Kangnam Sacred Heart Hospital
Enrollment
200
Locations
1
Primary Endpoint
Ocular surface disease index
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Dry eye syndrome and ocular surface disease are very important ophthalmologic diseases. It is known that various inducers are involved. However, it is still necessary to study how influencing factors are related to dry eye syndrome and ocular surface disease and how treatment for dry eye syndrome and ocular surface disease is helpful.

Registry
clinicaltrials.gov
Start Date
June 1, 2016
End Date
June 30, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hallym University Kangnam Sacred Heart Hospital
Responsible Party
Principal Investigator
Principal Investigator

Young Joo Shin

Principal Investigator

Hallym University Kangnam Sacred Heart Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with ocular discomfort related to DED who visit the Hallym University Kangnam Sacred Heart Hospital between June 2016 and June 2017.

Exclusion Criteria

  • Subjects who are elderly (≥80 years old) or have an autoimmune disease (e.g., Sjögren's syndrome and systemic lupus erythematosus) are excluded.

Outcomes

Primary Outcomes

Ocular surface disease index

Time Frame: 1 day

The ocular surface disease index survey in completed at the time of the exam. This scale ranges from 0 to 100 higher scores representing greater disability.

Secondary Outcomes

  • Schirmer tear secretion test(1 day)
  • Tear break-up time(1 day)
  • Corneal fluorescence staining(1 day)

Study Sites (1)

Loading locations...

Similar Trials